However, quantitative analysis comparing percentage change in areas of low- and high-density polyposis with placebo did not reach statistical significance.
← all excerpts
Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision.
1
—
—